Schedule 13D ownership disclosure
ENTASIS THERAPEUTICS HLDGS I
Security class unavailable · CUSIP: 293614103
Event date: 2020-06-11
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 2.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-20-172130
- Form type
- SC 13D
- Filer
- Entasis Therapeutics Holdings Inc.
- CIK
- CIK 1724344
- Filed
- Jun 18, 2020
- Reporting period
- Jun 11, 2020
- Description
- Schedule 13D beneficial ownership